A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.

Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.

Symptoms of Alkaptonuria

The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.

Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.

Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.

Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.

Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.

These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.

How is Alkaptonuria Diagnosed?

Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:

Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.

Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.

Blood Tests: High levels of HGA in the blood can be used as further evidence.

Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.

Management of Alkaptonuria: Is There A Cure?

At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:

Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.

Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.

Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.

Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.

Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.

Life with Alkaptonuria

Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.

Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.

As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.

Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.

Endometriosis is a chronic disease affecting about 1 in 10 women worldwide. Diagnosis and treatment remain challenging, particularly for women with severe pain and other complications.

Now, US researchers have developed a targeted nanotherapy that showed promising results against endometriosis in early testing.

Scientists at Washington State University found that the treatment reduced endometriosis lesions, symptoms and pain sensitivity after a single dose in mice.

The findings were published in Advanced Healthcare Materials. Researchers hope to eventually test the treatment in humans.

How Does The Drug Work?

Also read: Endometriosis Can Take Years To Diagnose But This AI Tool Can Identify Its Signs In 18 Milliseconds

The drug, niclosamide, was previously used to treat intestinal tapeworm infections in humans and is still used in animals.

Earlier research found that niclosamide could reduce endometriosis lesions and inflammation. However, it is not suitable for long-term use, limiting its potential as a treatment for a chronic condition.

To overcome this, researchers developed a nanotherapy that delivers niclosamide directly to cells associated with endometriosis.

“We found the disease-specific immune cell, and then we had a drug, but we couldn’t target the cell with the drug alone,” said Kanako Hayashi, professor at WSU’s School of Molecular Biosciences.

“So we used this nanocarrier that delivers the drug specifically to the disease site,” Hayashi said.

Single Dose Reduced Lesions In Mice

The team used a nanosized molecule called a dendrimer to bind with niclosamide and deliver it in a more soluble form.

In mice, a single injection reduced the size and number of lesions and lowered pain sensitivity.

“Although we still need to clear multiple phases, this study is telling us the efficacy is strong, and this nanocarrier is stable, so far, for two weeks—and we think we can go longer,” Hayashi said.

If the treatment remains stable for longer periods, researchers believe it could potentially be given less frequently. Hayashi said a monthly injection could be possible in the future, but this would depend on further testing.

READ: Endometriosis Taught Me To Always Listen To My Body, Says Model Padma Lakshmi

Can It Be Used In Humans?

Not yet. The treatment has only been tested in mice and must undergo further safety and efficacy testing before human trials.

Researchers also do not yet know whether it would ultimately be given as an injection or IV infusion.

What Is Endometriosis?

Endometriosis affects an estimated 190 million women worldwide. It occurs when tissue similar to the lining of the uterus grows outside the uterus.

It can cause severe pelvic pain, painful periods, pain during sex and infertility. Symptoms are sometimes dismissed as a “bad period,” contributing to delays in diagnosis.

There is currently no cure, although treatments can help manage symptoms.

How Is Endometriosis Treated?

Treatment depends on symptoms, disease severity and fertility goals.

Hormonal medicines can help control pain and disease activity but may cause side effects and can affect fertility while being used.

Painkillers, including non-steroidal anti-inflammatory drugs, may help manage discomfort.

Laparoscopic surgery can remove lesions and endometriotic cysts and may help restore pelvic anatomy. It can also improve fertility in some women, although the disease can recur.

Lifestyle measures such as regular exercise, stress management and dietary changes may also support symptom management.

Lung development of the fetus depends on the physical and genetic health of the parents.

At birth, breathing begins with air from the environment, containing oxygen and other gases, and is influenced by known and unknown forces of nature. The air then passes through well-developed nostrils, which regulate the air temperature and prevent foreign bodies from entering the body and help protect against diseases.

Breath travels through the nasal passages, sinuses, pharynx (throat), larynx (voice box), trachea (breathing tubes), bronchi, small airways, air sacs, interstitial membrane, into thin-walled blood vessels that transport oxygen and collect gases and other substances to be expelled from the body.

The diaphragm, the muscle that separates the lungs from the abdomen, is the most powerful breathing apparatus.

The lungs in the early stages of life undergo dramatic changes from newborn→ infancy→ childhood→ puberty→ teenage→ adults→ middle age→ seniors. Factors influencing lung health risks keep changing with age, depending on genetics, environment & external factors.

• Genetics or abnormalities – disorders at birth, transmitted from parents. Stress, environment, nutritional deficits, and accidents play an important role in lung and airway development. Also, anatomical abnormalities of the airways since birth, whether corrected or correctable or left alone.

• Allergy—genetic or acquired is lifelong unless well managed

• Chronic health conditions – Asthma can occur during childhood, pregnancy, post-pregnancy, or later in life and is generally manageable. Diabetes can develop during childhood, in young adulthood, or later in life, but it can be managed effectively. Hypertension, including pulmonary hypertension, can occur at any age and may be caused by blood clots, underlying diseases, primary conditions, or genetic factors.

• Environmental factors and unhealthy habits – smoking, pollution, gases, drugs, near-drowning. Recreational drugs, or side effects of medications used for diseases of the body, can have a telling effect on the lungs and airways.

• Nutrition – inadequate nutrition of mother and child can cause damage till old age

• Occupational lung disease – at any stage – workplace, smoking, birds, pets, pollution, construction activity, dusty atmospheres and travel, which may cause difficulty in breathing till later in life, leading to chronic obstructive lung disease that may cause morbidity.

• Infections – Can occur during childhood or throughout life, affecting both healthy individuals and those with reduced immune function, which may be due to co-existing diseases, medications that suppress the immune system to prevent rejection of transplanted organs, congenital immune deficiencies, or acquired immune deficiencies resulting from medications, external factors, or underlying diseases.

• Prophylactic medication, vaccines, and early treatment of airway diseases help in later life.

• Autoimmune diseases–arthritis, thyroid, etc.- where the body's defense mechanism has become rogue and fights itself, can develop from childhood till late in life.

• Accidents – happen at any age, damaging the breathing apparatus and requiring emergency treatment

• Cancer in any part of the body, including radiation, may affect the lungs at any age

• Body’s failure of in-built Immunity (innate) or acquired immunity mechanism; sunlight is nature’s gift to mankind; it improves lung resistance at all ages

• Snoring as an indicator for suspected obstructive sleep apnea

For Better Lung Health

• Exercise – yoga, sports, walking, physical and breathing exercises help to improve the performance of the respiratory tract throughout life

• Education – helps in understanding the causes, prevention, and timely treatment. It helps in averting damage to the airways in the future.

• Availability of health care facilities in urban & rural areas – can make a difference in the development, prevention, and treatment of respiratory disorders.

• Breastfeeding of the baby is important as it helps in the development and growth of the lungs, immunity, and fighting against damaging forces in nature, in the form of bacteria, viruses, fungi, prions, and a horde of known and unknown mechanisms which harm airways. Cough and sneeze reflexes begin to develop, which are powerful forces used to throw out unwanted particles and organisms from the airways.

The lungs and airways perform non-respiratory functions of protecting the body against harmful insults, both from within and external threats, and it also protects against insults received from other organs of the body. The lungs have a powerful defense mechanism protecting the body and also have hormonal, physical, and immunological defense mechanisms.

Every year on October 2, World No Alcohol Day urges people to pause and think about alcohol's place in everyday life. Here's where the day came from, and what current research actually shows about drinking.

World No Alcohol Day: Origins

It began in 2008, when India's then Union Health Minister, Dr. Anbumani Ramadoss, proposed a global alcohol-free day at the World Health Assembly in Geneva, according to National Day Calendar. The proposal drew support from 11 Southeast Asian countries.

The World Health Organization never formally adopted October 2 as an official global observance, according to a summary on Checkiday. There are, in fact, three dates tied to alcohol awareness worldwide: October 2 and October 3, observed by many groups as World Alcohol-Free Day or World Temperance Day, and November 15.

In India, October 2 is also a nationwide dry day, with no alcohol sales permitted, and is marked separately as National Anti-Drug Addiction Day.

Also Read: Does Experimental Obesity Drug Petrelintide Cause Fewer GI Side Effects Than Ozempic? Lancet Study Shows Promise

What Science Says About Alcohol Now

The science has shifted since 2008. In January 2023, the World Health Organization stated plainly that no level of alcohol consumption is safe for health, publishing the position in The Lancet Public Health. The WHO said current evidence cannot identify any threshold below which alcohol's cancer-causing effects switch off.

Alcohol is classified as a Group 1 carcinogen, the same risk category as tobacco and asbestos, and is linked to at least seven types of cancer, including the most common cancers in men and women, bowel and breast cancer, according to the WHO.

Globally, alcohol was responsible for an estimated 741,300 new cancer cases and contributed to nearly 400,000 cancer deaths in a single year, as per Lancet-based estimates cited by the Union for International Cancer Control.

Previous research has showed some benefits of wine, but the majority scientific consensus now is that there is no safe levels of alcohol. The World Health Organization says health risks begin with the first drop of alcohol, meaning no level of consumption is completely safe or risk-free.

The toll beyond cancer

Cancer isn't the only risk. Alcohol use is tied to roughly 2.5 million deaths worldwide each year, including 320,000 among people aged 15 to 29, according to the WHO. Beyond individual health, alcohol-related harm also means more road accidents, violence, and strain on healthcare systems.

A May 2026 study linked alcohol to 62 disorders, ranging from heart and digestive diseases to mental and neurological conditions and cancers.

The study, published in the journal Addiction, showed that the fully alcohol-attributable conditions are mainly grouped under non-communicable diseases and injuries.

These include:

• Endocrine, nutritional, and metabolic diseases
• Mental and behavioral disorders
• Diseases of the nervous system
• Diseases of the circulatory system, such as alcoholic cardiomyopathy
• Digestive diseases
• Alcoholic liver disease and cirrhosis.

The data also included psychotic disorders, gastritis, ulcers, pancreatitis, fatty liver disease, pregnancy- and perinatal-related conditions such as fetal alcohol syndrome and fetal alcohol spectrum disorders, as well as external causes and injuries, including alcohol poisoning.

Excessive alcohol consumption is one of the leading preventable causes of illness and death in the US, according to the Centers for Disease Control and Prevention.

Research shows that alcohol accounts for approximately half of all liver-related deaths, while alcohol-associated cirrhosis has become the leading cause of liver transplants.